Purchase Order HHSN269201700334P
Award Date
4/28/17
Potential Completion Date
9/19/23
Potential Value
$112K
Federal Agency
NIH Clinical Center
Awardee
Profounda Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products. The contract, valued at $96,000.00, is for the delivery of Impavido/Miltefosine, a critical medication used to treat leishmaniasis and other drug-resistant infections, with a focus on providing emergency pharmaceutical solutions to veterans. Profounda Inc. has a...
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA), specifically Veterans Integrated Service Network (VISN) 20, to Profounda Inc. for the delivery of Impavido/Miltefosine, a critical medication used to treat leishmaniasis and other drug-resistant infections. The contract, valued at $16,650.00, does not have a set-aside designation and is intended to support the VA's mission of providing healthcare services to veterans by ensuring rapid access to...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Profounda Inc., a self-certified small disadvantaged business. The $49,950.00 contract is for the delivery of Profounda's Impavido/Miltefosine pharmaceutical product to the VA Sunshine Healthcare Network (VISN 20) in Orlando, Florida. Impavido/Miltefosine is used to treat leishmaniasis and other drug-resistant infections in veterans. This award is the latest in a...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs' (VA) Veterans Health Administration (VHA) to Profounda Inc., a self-certified small disadvantaged business and manufacturer. The $116,550 contract is for the delivery of Miltefosine, a medication used to treat leishmaniasis and other drug-resistant infections in veterans. The contract has an ultimate completion date of September 30, 2024 and is part of a larger $1,127,000 Blanket Purchase Agreement (BPA)...
The Department of Veterans Affairs' Veterans Health Administration awarded a firm fixed-price purchase order to Profounda Inc., a self-certified small disadvantaged business, to provide Miltefosine drug with a potential value of $149,950.00. The order, placed under the VHA's Veterans Integrated Service Network 23, supports the agency's mission to deliver healthcare services to veterans by ensuring access to this specialized pharmaceutical product needed for treatment. Profounda has previously...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded a $16,750 purchase order to Profounda Inc. for the delivery of 50mg miltefosine capsules. The firm fixed price contract runs from December 14, 2023 through January 13, 2024 and will be performed in Omaha, Nebraska. Profounda Inc. will provide the pharmaceutical products to VA-VHA under this contract to support their healthcare services for veterans. No subcontractors or set aside...
This is a $19,905 firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Proaim Americas, LLC, a minority-owned limited liability company doing business as Proaim Medical. The contract is for the delivery of a specialized bioinductive implant with arthroscopic delivery medical device. Proaim Americas is an established federal government distribution and contracting organization that has received over $2 million in prime contracts and delivery orders from...
This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs (VA) to Proaim Americas, LLC, doing business as Proaim Medical, for the provision of a prosthetic implant. The contract has a ceiling value of $27,716.00 and a completion date of February 28, 2025. Proaim Americas is a minority-owned, for-profit limited liability company that has been awarded over $2 million in federal contracts over the...
This federal contract award, valued at $17,306.80, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Proaim Americas, LLC, a minority-owned, for-profit limited liability company doing business as Proaim Medical. The contract is a delivery order for a "BIOINDUCTIVE IMPLANT W/ARTH DEL MED" and has a firm fixed price pricing type with a completion date of June 3, 2024. Proaim Americas is a key supplier of advanced medical technologies and equipment...
Proaim Americas, LLC, doing business as Proaim Medical, has been awarded a $39,870.82 firm fixed-price purchase order contract by the National Institutes of Health (NIH) Clinical Center. The contract is for the provision of specialized medical devices, instruments, implants, equipment, and software to support federal healthcare agencies. This contract is not a set-aside. Proaim Americas is a federal government distribution and contracting organization that has been awarded over 50 prime...